切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2021, Vol. 10 ›› Issue (06) : 654 -658. doi: 10.3877/cma.j.issn.2095-3224.2021.06.014

经验交流

机器人辅助直肠癌切除经自然腔道取标本手术(NOSES)联合多脏器切除术的应用
武琦1, 陈伊教1, 朱德祥1,(), 韦烨1,(), 许剑民1   
  1. 1. 200032 上海,复旦大学附属中山医院普外科;200032 上海结直肠肿瘤微创工程技术研究中心;200032 复旦大学附属中山医院肿瘤防治中心
  • 收稿日期:2021-06-29 出版日期:2021-12-25
  • 通信作者: 朱德祥, 韦烨
  • 基金资助:
    国家自然科学基金面上项目(82072678); 上海市科委项目(19511121300); 上海申康医院发展中心临床三年行动计划资助(SHDC2020CR1033B,SHDC2020CR5006)

The application of robot-assisted natural orifice specimen extraction surgery in the combined with multiple organ resection in rectal cancer

Qi Wu1, Yijiao Chen1, Dexiang Zhu1,(), Ye Wei1,(), Jianmin Xu1   

  1. 1. Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Shanghai Engineering Research Cencer of Colorectal Cancer Minimally Invasive technology, Shanghai, 200032, China; Cancer center Zhongshan Hospital, Shanghai, 200032, China
  • Received:2021-06-29 Published:2021-12-25
  • Corresponding author: Dexiang Zhu, Ye Wei
引用本文:

武琦, 陈伊教, 朱德祥, 韦烨, 许剑民. 机器人辅助直肠癌切除经自然腔道取标本手术(NOSES)联合多脏器切除术的应用[J/OL]. 中华结直肠疾病电子杂志, 2021, 10(06): 654-658.

Qi Wu, Yijiao Chen, Dexiang Zhu, Ye Wei, Jianmin Xu. The application of robot-assisted natural orifice specimen extraction surgery in the combined with multiple organ resection in rectal cancer[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2021, 10(06): 654-658.

目的

探讨达芬奇机器人辅助直肠癌切除经自然腔道取标本手术(NOSES)联合多脏器切除术的安全性和可行性。

方法

回顾性收集2013年10月至2021年2月复旦大学附属中山医院结直肠外科收治的使用机器人辅助直肠癌NOSES手术患者的临床资料,选取术中进行多脏器联合切除的11例患者,分析其临床病理特征和围手术期相关结果。

结果

共有11例患者接受机器人辅助直肠癌NOSES手术联合多脏器切除术,其中男性2例(2/11),女性9例(9/11),平均年龄(56.0±11.2)岁,8例低位直肠癌(8/11),2例中位直肠癌(2/11),1例高位直肠癌(1/11)。术前合并糖尿病1例(1/11),高血压2例(2/11),冠心病1例(1/11)。全组患者均顺利完成机器人辅助直肠癌切除NOSES联合多脏器切除术,其中联合全子宫双附件切除4例,联合子宫切除术1例,联合小肠及全子宫双附件切除1例,联合肺转移灶切除1例,卵巢囊肿切除1例,胆囊切除1例,肝ALPPS手术1例,肝叶切除术1例。全组平均手术时间为(175.5±48.2)min,平均出血量为(33.6±19.1)mL。无中转开腹病例,全组无术中输血。所有患者上下切缘与环周切缘均为阴性。无围术期死亡。2例患者(2/11)发生术后并发症(1例小肠不全梗阻,1例肺部感染),均保守治疗后好转。术后平均排气时间(74.2±33.1)小时,术后平均住院时间为(5.9±0.9)天,术后平均辅助治疗开始时间为(18.3±5.4)日。术后病理TNM分期Ⅱ期2例(2/11),Ⅲ期4例(4/11),Ⅳ期5例(5/11)。

结论

有经验的外科团队在合适的直肠癌患者中施行机器人辅助直肠癌切除NOSES联合多脏器切除术安全可行。

Objective

To explore the safety and feasibility of Da Vinci robot-assisted natural orifice specimen extraction surgery (NOSES) for the combined resection of rectal cancer with multiple organs.

Methods

During October 2013 to February 2021, totally 11 patients undergoing this surgery in the department of colorectal surgery, Zhongshan Hospital of Fudan University were included into presented retrospective study. The analysis content includes the patient's baseline condition, surgery condition, postoperative condition and so on.

Results

Of the 11 patients in the whole group, included 2 males (2/11) and 9 females (9/11) with average age of (56.0±11.2) years, 8 low rectal cancer patients (8/11), 2 middle rectal cancer patients (2/11) and 1 high rectal cancer patients (1/11). One case (1/11) had diabetes mellitus, 2 cases (2/11) had hypertension and 1 case (1/11) had coronary heart disease. Whole group of patients were successfully completed robot assisted NOSES combined multiple organ resection of rectal cancer excision, which combined the uterus double appendix resection in 4 cases, combined hysterectomy in 1 case, combined the small intestine and the uterus double appendix resection in 1 case, combined lung metastases resection in 1 case, ovarian cyst resection in 1 case, cystic resection in 1 case, liver ALPPS surgery in 1 case, lobe resection in 1 case. The mean operation time was (175.5±48.2) min and the mean blood loss was (33.6±19.1) mL. No patient was transferred to laparotomy, and no intraoperative blood transfusion was found in the whole group. The upper and lower margins and circumferential margins were negative in all patients. There were no perioperative deaths. Postoperative complications occurred in 2 patients (2/11) (1 case intestinal insufficiency obstruction, 1 case pulmonary infection), all of which improved after conservative treatment. The mean postoperative exhaust time was (74.2±33.1) hours, the mean postoperative hospital stay was (5.9±0.9) days, and the mean postoperative adjuvant treatment start time was (18.3±5.4) days.Postoperative pathological TNM stages were stage Ⅱ in 2 patients (2/11), stage Ⅲ in 4 patients (4/11) and stage Ⅳ in 5 patients (5/11).

Conclusion

It is safe and feasible to perform robot-assisted NOSES multiple organ resection for eligible patients with rectal cancer under comprehensive evaluation.

[1]
Lu Z, Chen H, Zhang M, et al. Safety and survival outcomes of transanal natural orifice specimen extraction using prolapsing technique for patients with middle- to low-rectal cancer[J]. Chin J Cancer Res, 2020, 32(5): 654-664.
[2]
关旭, 王贵玉, 周主青, 等. 79家医院718例结直肠肿瘤经自然腔道取标本手术回顾性研究[J]. 中华结直肠疾病电子杂志, 2017, 6(6): 469-477.
[3]
Delaney CP, Lynch AC, Senagore AJ, et al. Comparison of robotically performed and traditional laparoscopic colorectal surgery[J]. Dis Colon Rectum, 2003, 46(12): 1633-1639.
[4]
中国医师协会结直肠肿瘤专业委员会机器人手术专业委员会, 中国研究型医院学会机器人与腹腔镜外科专业委员会. 机器人结直肠癌手术中国专家共识(2020版)[J]. 中华消化外科杂志, 2021, 20(1): 16-28.
[5]
Addison P, Agnew JL, Martz J. Robotic colorectal surgery[J]. Surg Clin North Am, 2020, 100(2): 337-360.
[6]
汤思哲, 王仆, 孔大陆. 达芬奇机器人手术系统结直肠癌根治术的现状和展望[J]. 中国肿瘤临床, 2019, 7(7): 370-374.
[7]
Chang TP, Chok AY, Tan D, et al. The emerging role of robotics in pelvic exenteration surgery for locally advanced rectal cancer: a narrative review[J]. J Clin Med, 2021, 10(7): 1518.
[8]
Pelvex Collaborative. Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration[J]. Ann Surg, 2019, 269(2): 315-321.
[9]
中华人民共和国国家卫生健康委员会. 中国结直肠癌诊疗规范(2020年版)[J]. 中华外科杂志, 2020, 58(8): 561-585.
[10]
王锡山. 结直肠肿瘤治疗的微创和功能外科理念在实践与探索中前行[J/CD]. 中华结直肠疾病电子杂志, 2013, 3(3): 106-108.
[11]
郑民华, 马君俊. 微创技术在结直肠肿瘤手术功能保护的优势与弊端[J]. 中华胃肠外科杂志, 2017, 20(6): 601-605.
[12]
Xu J, Tang B, Li T, et al. Robotic colorectal cancer surgery in China: a nationwide retrospective observational study[J]. Surg Endosc, 2020, 35(12): 6591-6603.
[13]
Milone M, Manigrasso M, Velotti N, et al. Completeness of total mesorectum excision of laparoscopic versus robotic surgery: a review with a meta-analysis[J]. Int J Colorectal Dis, 2019, 34(6): 983-991.
[14]
Zhou S, Wang X, Zhao C, et al. Comparison of short-term and survival outcomes for transanal natural orifice specimen extraction with conventional mini-laparotomy after laparoscopic anterior resection for colorectal cancer[J]. Cancer Manag Res, 2019, 1(11): 5939-5948.
[15]
王玉柳明, 张骞, 郁雷, 等. 结直肠肿瘤经自然腔道取标本手术203例回顾性研究[J/CD]. 中华结直肠疾病电子杂志, 2019, 8(1): 32-37.
[16]
Wolthuis AM, Fieuws S, Van Den Bosch A, et al. Randomized clinical trial of laparoscopic colectomy with or without natural-orifice specimen extraction[J]. Br J Surg, 2015, 102(6): 630-637.
[17]
牛正川, 韦烨, 朱德祥, 等. 机器人腹部无切口直肠癌前切除术[J/CD]. 中华结直肠疾病电子杂志, 2018, 7(4): 332-336.
[18]
Chen J, Zhang Z, Chang W, et al. Short-term and long-term outcomes in mid and low rectal cancer with robotic surgery[J]. Front Oncol, 2021, 9(11): 603073.
[19]
王锡山. 结肠直肠癌联合脏器切除若干问题思考[J]. 外科理论与实践, 2016, 21(6): 461-463.
[20]
Nanayakkara PR, Ahmed SA, Oudit D, et al. Robotic assisted minimally invasive pelvic exenteration in advanced rectal cancer: review and case report[J]. J Robot Surg, 2014, 8(2): 173-175.
[21]
Heah NH, Wong KY. Feasibility of robotic assisted bladder sparing pelvic exenteration for locally advanced rectal cancer: A single institution case series[J]. World J Gastrointest Surg, 2020, 12(4): 190-196.
[22]
Raj Kumar B, Bankar S, Pandey D, et al. Abdominoperineal excision with prostatectomy in T4 rectal cancer - bladder-sparing robotic pelvic exenteration - a video vignette[J]. Colorectal Dis, 2020, 22(11): 1786-1787.
[23]
Shin US, Nancy You Y, Nguyen AT, et al. Oncologic outcomes of extended robotic resection for rectal cancer[J]. Ann Surg Oncol, 2016, 23(7): 2249-2257.
[24]
Mañas MJ, Espín E, López-cano M, et al. Multivisceral resection for locally advanced rectal cancer: prognostic factors influencing outcome[J]. Scand J Surg, 2015, 104(3): 154-160.
[25]
Kim KY, Hwang DW, Park YK, et al. A single surgeon's experience with 54 consecutive cases of multivisceral resection for locally advanced primary colorectal cancer: can the laparoscopic approach be performed safely?[J]. Surg Endosc, 2012, 26(2): 493-500.
[26]
Hino H, Yamaguchi T, Kinugasa Y, et al. Robotic-assisted multivisceral resection for rectal cancer: short-term outcomes at a single center[J]. Tech Coloproctol, 2017, 21(11): 879-886.
[27]
姜勇, 吴涛, 万远廉, 等. cT4bM0期原发直肠癌的外科治疗及预后分析[J]. 中华消化外科杂志, 2013, 6(6): 417-421.
[1] 王振宁, 杨康, 王得晨, 邹敏, 归明彬, 王雅楠, 徐明. 机器人与腹腔镜手术联合经自然腔道取标本对中低位直肠癌患者远期疗效比较[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 437-442.
[2] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[3] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[4] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[5] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[6] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[7] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[8] 郑民华, 蒋天宇, 赵轩, 马君俊. 中国腹腔镜直肠癌根治术30年发展历程与未来[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 591-595.
[9] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[10] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[11] 陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[12] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[13] 王灿, 樊昊, 张卫, 于冠宇. LARS 评分的研制回顾与应用现状[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 519-523.
[14] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[15] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?